Earnings

OneMedNet Reports QQ3 Preliminary Revenue Of ~$1M, Up 465% YoY; Anticipates Q4 Revenue Range $12M - $14M

Nov 6, 2026 · 08:34 AM ET· updated 1h ago

OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven

Why It Matters

OneMedNet's sales grew a lot from last year, about four hundred sixty five percent. The company expects much bigger sales numbers coming in the next quarter.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ONMD4.67

+0.50 (+12.09%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.